# Apozeal Pharmaceuticals Inc. – FDA Inspection, Apr 9, 2019

Source: https://www.keypedia.com/records/fda_inspections/apozeal-pharmaceuticals-inc/a1f553bf-210b-4f01-81a3-d4276c44e2b1
Source feed: FDA_Inspections

> FDA inspection 1085686 of Apozeal Pharmaceuticals Inc., April 09, 2019. Classification: Official Action Indicated (OAI). 8 citations under 21 CFR part 211. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1085686
- Company Name: Apozeal Pharmaceuticals Inc.
- Inspection Date: 2019-04-09
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Documents

- [FDA Inspection 1287054 - 2025-10-15](https://www.keypedia.com/records/fda_inspections/apozeal-pharmaceuticals-inc/5cedf772-ff92-416e-9e31-51a75fbf805a)
- FDA Inspection 1161191 - 2021-12-15
- FDA Inspection 1073461 - 2018-11-09
- [FDA Inspection 1060369 - 2018-07-26](https://www.keypedia.com/records/fda_inspections/apozeal-pharmaceuticals-inc/cee55502-d071-4de9-a21f-1346cb5d1ccb)
- [FDA Inspection 1040076 - 2018-02-07](https://www.keypedia.com/records/fda_inspections/apozeal-pharmaceuticals-inc/cac43cea-0ad1-4497-8efd-7c750e795e59)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/christina-k-theodorou/3c18d958-14de-4f25-9fbd-7358205155f7)
- [Company Rep](https://www.keypedia.com/people/dandan-wang/d305aa00-763c-4cbe-8e95-8821f7f67181)
- Issuing Officer

Company: https://www.keypedia.com/companies/apozeal-pharmaceuticals-inc/0eae3e34-426a-4c5f-a067-d762962ea916

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
